Last week we attended the European Society for Medical Oncology (ESMO) Congress 2022, gathering the world’s leading oncologists. Read our summary of three presentations illustrating cancer therapy development.
With over 1.3 million women worldwide diagnosed with gynaecological cancers in 2020, it’s more important now than ever to equip them with tools and resources to promote prevention and early detection of potential cancers.
Cancer management outcomes can strongly benefit from robust and accurate detection of gene fusions. SOPHiA GENETICS developed the SOPHiA DDM Dx RNAtarget Oncology Solution to make this possible.
We list 7 reasons to consider SOPHiA DDM Dx RNAtarget Oncology Solution for your assays.
Last week we attended the 2022 American Society of Clinical Oncology (ASCO) meeting, gathering the world’s leading researchers in oncology. Read our summary of four groundbreaking presentations on breast cancer research.
Q&A with the Clinical Application Product Manager, Mikhail Pertziger, PhD
Microsatellite Instability: how do microsatellites mutations correlate with cancer?
How Protean BioDiagnostics utilizes SOPHiA GENETICS for more comprehensive genomic analysis and research
Larger panels may cast wider nets, but optimization with patented algorithms through our universal platform gives more actionable insights without sacrificing data quality.
Learn about the impact of HRD in cancer development, how HRD status may predict sensitivity to certain treatments, and the different HRD testing methods available.
The President acknowledged that the US still has much further to come in advancing data-driven initiatives and that many Americans sadly do not realize the struggle of seeking answers during the cancer diagnostic journey until it’s too late.
About half of all breast cancer patients develop the disease outside of the period of ages 50-69 and could greatly benefit from earlier detection. Today, we know that age alone is not enough to accurately estimate breast cancer risk.
The medical research community has been buried in data since well before the global COVID-19 pandemic. How they’re now managing the extreme additional influx of SARS-CoV-2 data determines the outcomes of a lab’s overall research capabilities.
You never know when life is going to throw you a curve ball. You can plan for something to happen down to the dotted line, but a simple phone call can change your whole perspective on life.